A groundbreaking study from the University of Cambridge reveals a new drug that can significantly reduce brain damage caused ...

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke.

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when ...

The countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast ...

The National Natural Science Foundation of China (No. 82071305, 82301512, 82302474) Chongqing Postdoctoral Science Foundation ...

Ischemic stroke is a leading cause of death and disability worldwide, with many patients experiencing poor outcomes despite ...

Infusion of tiny mitochondria helps rejuvenate tissues, so researchers hope the technique could treat a variety of damaged ...

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced that the U.S. Food and Drug Administration has granted Fast ...

US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke: Tacoma, Washington Saturday, August 2, 2025, 15:00 Hrs [I ...

Traumatic brain injury (TBI) remains one of the leading causes of disability worldwide. Recent research has developed a novel ...